CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNY

Isatuximab SC-OBDS

Phase 2
Sanofi (SNY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q1 '27
SNYPhase 2

Isatuximab SC-OBDS Phase 2 Est. Readout

Isatuximab SC-OBDS
Q1 2027~QSTALE
CT.gov
00%
Competitive Landscape

0 competitors in Plasma Cell Myeloma Refractory

View Full Landscape
Drug Information

Target Indication

Plasma Cell Myeloma Refractory

Clinical Trial

NCT06356571

Last updated: 1/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.